Morepen Research Institute Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Months 4 Days
About Morepen Research Institute
Morepen Research Institute Private Limited (MRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 August 2024 ( five months 4 days old ). Its registered office is in New Delhi, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sushil Suri, Sanjay Suri, and Kushal Suri serve as directors at the Company.
Company Details
-
Location
New Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72100DL2024PTC436080
-
Company No.
436080
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Aug 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Morepen Research Institute?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Suri
|
Director | 29-Aug-2024 | Current |
|
Sushil Suri
|
Director | 29-Aug-2024 | Current |
|
Kushal Suri
|
Director | 29-Aug-2024 | Current |
Financial Performance of Morepen Research Institute.
Enhance accessibility to Morepen Research Institute's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Morepen Research Institute?
Unlock access to Morepen Research Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Blue Coast Hotels LimitedKushal Suri is a mutual person
-
Blue Coast Hospitality Limited
Kushal Suri is a mutual person
-
Morepen Laboratories LimitedSushil Suri and Sanjay Suri are mutual person
-
Morepen Devices Limited
Sushil Suri is a mutual person
-
Morepen Rx Limited
Sanjay Suri is a mutual person
-
Morepen Bio Limited
Sanjay Suri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Morepen Research Institute?
Unlock and access historical data on people associated with Morepen Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Morepen Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morepen Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.